Published peptide research references
Efpeglenatide
Governed registry record
3 approved source records with original-source links. Source verification confirms the reference and its connection to this record; it does not certify every scientific conclusion or establish safety or efficacy.
Approved source records
Cardiovascular Effects and Tolerability of GLP-1 Receptor Agonists: A Systematic Review and Meta-Analysis of 99,599 Patients.
DOI: 10.1016/j.jacc.2025.08.027PMID: 40892610
Source identity and connection checked by Codex (AI).
Cardiovascular and Renal Outcomes with Efpeglenatide in Type 2 Diabetes.
Source identity and connection checked by Codex (AI).
Comparison of the efficacy and safety of GLP-1 receptor agonists on cardiovascular events and risk factors: A review and network meta-analysis.
Source identity and connection checked by Codex (AI).
Legacy research context
Context from the legacy curated dataset. Its counts describe that dataset and are separate from the live approved source records above.
Researchers represented
- Gerstein HC
- Sattar N
- Rosenstock J
- Ramasundarahettige C
- Pratley R
- Lopes RD
- Lam CSP
- Khurmi NS
- Heenan L
- Del Prato S
- Dyal L
- Branch K
- AMPLITUDE-O Trial Investigators
- Galli M
- Benenati S
- Laudani C
- Simeone B
- Sarto G
- Ortega-Paz L
- Rocco E
- Bernardi M
- Spadafora L
- D'Amario D
- Greco E
- Frati G
- Federici M
- Mehran R
- Crea F
- Angiolillo DJ
- Sciarretta S
- An X
- Sun W
- Wen Z
- Duan L
- Zhang Y
- Kang X
- Ji H
- Sun Y
- Jiang L
- Zhao X
- Gao Q
- Lian F
- Giugliano D
- Scappaticcio L
- Longo M
- Caruso P
- Maiorino MI
- Bellastella G
- Ceriello A
- Chiodini P
- Esposito K